SEC Form 4 · accession 0002140098-26-000005
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuele Butera
Officer — SVP, GM, Global Respiratory
Period of report
Jun 23, 2026
Accepted (ET)
Jun 24, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001104506
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 23, 2026 | A | 7,342 | — | A | 7,342 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $102.15 | Jun 23, 2026 | A | 12,570 | A | — | Jun 23, 2036 | Common Stock | 12,570 | 12,570 | D |
Explanation of responses
- F1Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
- F2Each RSU was granted on June 23, 2026, for no consideration.
- F3These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.